Marilyn Ling, M.D.

Contact Information:

University of Rochester Cancer Center
Department of Radiation Oncology
601 Elmwood Ave, Box 647
Rochester, NY 14642

Phone: (585) 275-5624
Fax: (585) 275-1531
E-mail: marilyn_ling@urmc.rochester.edu

Biographical Sketch

Dr. Ling attended Williams College and recieved a BA in Biology in 1983. In 1984, she was awarded a Certificat de Mérite from the Cordon Bleu Académie de Cuisine in Paris, France. She then went on to medical school at the University of Maryland and recieved her M.D. in 1988. At Lenox Hill Hospital, from 1988 to 1989 she was an intern. She was a resident in Radiation Oncology at Johns Hopkings Hospital in 1991 and a Chief Resident and Fellow in Radiation Oncology in 1992. From 1992 to 1994, she was an Instructor in Radiation Oncology at the Tufts University School of Medicine. She was a Visiting Scientist in 1995 to the Nuclear Research Laboratory at the Massachusetts Institute of Technology. Dr. Ling was in Seattle from 1997 to 1999 as a Clinical Assistant Professor at the University of Washington Medical Center. Since 1999 she has been an Assistnat Professor at the U of R School of Medicine and Dentistry.

Clinical Specialty
Research Overview
Selected Honors
Education
Academic Appointments
Hospital Appointments
Major Committees
Publications
Radiation Oncology Home

Research Overview

1996. Investigator: A Phase II Trial of Fractionated Intensity-modulated Conformal Radiation Therapy in the Treatment of Recurrent High Grade Glioma. New England Medical Center

1996. Investigator: Evaluation of the Efficacy, Safety, and Reliability of the Peacock System for Conformal Radiation Therapy in the Treatment of Selected Patients with Tumors and Arteriovenous Malformations. New England Medical Center

1995. Investigator: Protocol for Phase-I Student of Boron Neutron Capture Therapy for Glioblastoma Multiforme & Intracranial Melanoma at New England Medical Center & The Massachusetts Institute of Technology

1994-1996. Investigator: Phase II Trial of 13 cis-Retinoic Acid and Interferon alpha-2a in Patients with Low Grade Gliomas. New England Medical Center

1994-1996. Investigator: The Role of Prophylaxis Treatment with Phenytoin in Patients with Metastatic Brain Tumor. New England Medical Center

Education

1988. Doctor of Medicine University of Maryland School of Medicine Baltimore, MD

1983. Bachelor of Arts, Biology Williams College Williamstown , MA

1992. Chief Resident and Fellow in Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD

1991. Resident in Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD

1988-1989. Internship in Medicine, Lenox Hill Hospital, New York, NY

1984 Certificat de Mérite, Cordon Bleu Académie de Cuisine, Paris, France

1984. Radioimmunology Associate, Johns Hopkins Hospital Baltimore, MD

Academic Appointments

2003. Medical Faculty Council, University of Rochester Medical Center\r\n

2001-Present. Compliance Liaison, University of Rochester Medical Center\r\n

1999-Present. Attending Radiation Oncologist, University of Rochester School of Medicine & Dentistry, 601 Elmwood Ave., Rochester, NY 14642\r\n

1997-9. Attending Radiation Oncologist, University of Washington Medical Center, 1959 N.E. Pacific Street, Seattle, WA 98195-6043\r\n

1997-8. Attending Radiation Oncologist, Veterans Administration Medical Center, Puget Sound Health Care System, 1660 S. Columbia Way, Seattle, WA 98108\r\n

1996-7. Attending Radiation Oncologist, Adventist Medical Center, 10123 SE Market Street, Portland, OR 97216\r\n

1996-7. Attending Radiation Oncologist, Southwest Washington Medical Center, 400 NE Mother Joseph Place, Vancouver, WA 98668\r\n

1996. Consultant Radiation Oncologist, Veterans Administration Medical Center, 150 South Huntington Avenue, Boston, MA 02130\r\n

1997. Consultant Radiation Oncologist, Newton-Wellesley Hospital, 2014 Washington Street, Newton, MA 02162\r\n

1992-6. Attending Radiation Oncologist, New England Medical Center, 750 Washington Str, Boston MA 02111

Hospital Appointments

1999-Present. Assistant Professor, University of Rochester, School of Medicine & Dentistry, Rochester, NY

1997-1999. Clinical Assistant Professor, University of Washington Medical Center, Seattle, Washington

1995. Visiting Scientist, Nuclear Reactor Laboratory, Massachusetts Institute of Technology, Cambridge, MA

1996. Assistant Professor in Radiation Oncologist, Tufts University School of Medicine, Boston, MA

1992-1994. Instructor in Radiation Oncology, Tufts University School of Medicine, Boston, MA

Publications

Klein JL, Ling MN, Leichner PK, Kopher KA, Rostock RA, Order SE: A Model System that Predicts Effective Half-Life for Radiolabeled Antibody Therapy. Int. J. Radiation Oncology Biol. Phys., 11: 1489-1494, 1985.

Chun M, Timmerman RD, Mayer R, Ling MN, Sheldon J, Fishman EK: Radiation Therapy of External Iliac Lymph Nodes with Lateral Pelvic Portals: Identification of Patients at Risk for Inadequate Regional Coverage. Radiology, 194: 147-150, 1995.

Ulin K, Bornstein LE, Ling MN, Saris S, Wu JK, Curran BH, Wazer DE: A Technique for Accurate Planning of Stereotactic Brain Implants Prior to Head Ring Fixation. Int. J. Radiation Oncology Biol. Phys., 39(3): 757-767, 1997.

Geiger M, Wu JK, Ling MN, Wazer DE, Tsai JS, Engler M: Response of Intracranial Melanoma Metastases to Stereotatic Radiosurgery. Rad. Oncol. Invest., 5(2): 72-80, 1997.

Tsai JS, Wazer DE, Ling MN, Wu JK, Fagundes M, DiPetrillo T, Kramer B, Koistinen M, Engler MJ: Dosimetric Verification of the Dynamic Intensity-Modulated Radiation Therapy of 92 Patients. Int. J. Radiation Oncology Biol. Phys., 40(5): 1213-30, 1998.

Kramer BA, Wazer DE, Engler MJ, Tsai JS, Ling MN: Dosimetric Comparison of Stereotactic Radiosurgery to Intensity Modulated Raditherapy. Rad. Oncol. Invest., 6(1): 18-25, 1998.

Tsai JS, Engler M, Ling MN, Wu J, DiPetrillo T, Wazer DE: A Non-invasive Immobilization System and Related Quality Assurance for Dynamic Intensity Modulated Radiation Therapy of Intracranial and Head and Neck Disease. Int. J. Radiation Oncology Biol. Phys., 43(2): 455-467, 1999.